Determination of megestrol acetate and cyproterone acetate in serum of patients with advanced breast cancer by high-performance liquid chromatography
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 529 (1) , 145-154
- https://doi.org/10.1016/s0378-4347(00)83815-3
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Endocrine therapy of breast cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- Clinical and endocrine effects of cyproterone acetate in postmenopausal patients with advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- Randomized trial of tamoxifen alone or combined with aminoglutethimide and hydrocortisone in women with metastatic breast cancer.Journal of Clinical Oncology, 1986
- Specific and sensitive determination of medroxyprogesterone acetate in human serum by gas chromatography mass spectrometryJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Additive hormonal therapy in women with advanced breast cancerCancer, 1984
- Treatment of metastatic breast cancer patients with different dosages of megestrol acetate; dose relations, metabolic and endocrine effectsEuropean Journal of Cancer and Clinical Oncology, 1984
- TamoxifenJAMA, 1979
- Treatment of Breast Cancer with Medroxyprogesterone AcetateAnnals of Internal Medicine, 1968
- Progestin therapy of breast cancer: comparison of agents.BMJ, 1967
- Hormonal therapy in cancer of the breast.III. Effect of progesterone on clinical course and hormonal excretionCancer, 1952